bold = Main text
     Part,  Chapter, Paragraphgrey = Comment text

9006 II, 9. 4. 7 | http://www.healthyageing.nu/upload/pdf/Chapters%20from%20the% 9007 III, 10. 5. 1 | weknow-waternetwork.com/uploads/booklets/05_small_water_ 9008 I, 2. 6 | close to 100 for basic and upper-secondary education. For tertiary 9009 III, 10. 4. 5 | causing the illness to an upstream host. Moreover, toxic algal 9010 III, 10. 3. 1 | the ground in areas with uranium-containing soils and rocks. The most 9011 II, 5. 5. 3 | figures (gender, migrants, urbanicity). Hence, detailed data are 9012 III, 10. 5. 2 | seems easier to defineurbanism” and then label as “rural” 9013 II, 5. 5. 3 | eaManceau E, Lucas B, Lemesle M, Urbinelli R, Giroud M (2000): Incidence 9014 II, 6. 3. 6 | haemorrhages: haemolytic uremic syndrome (HUS). HUS is the 9015 III, 10. 2. 1 | Atherosclerosis*~Kidney and ureter~COPD, asthma and other respiratory 9016 II, 9. 3. 1 | functional layers of the urethraepithelium, connective 9017 IV, 11. 1. 5 | and passed a resolution urging the World Health Organization 9018 III, 10. 2. 4 | 50:1418-1422.~ ~Hoos A, Urist MJ, Stojadinovic A, Mastorides 9019 II, 9. 3. 1 | Randomized Controlled Trial Eur Urol 51: 659-664~ ~Austbury J: ( 9020 II, 9. 3. 1 | neurological problems, urological surgical and many prescription 9021 II, 5. 8. 7 | Norbäck D, d'Errico A, Urrutia I, Payo F, Olivieri M, Villani 9022 II, 5. 10. 3 | food - namely skin rash/urticaria, rhinitis, vomiting, diarrhoea, 9023 II, 6. 4. 4 | institutes of the EU, the US-CDC, Canada and other parts 9024 I, 2. 10. 3 | improve accessibility and usability of digital material in a 9025 IV, 11. 3. 1 | that are acknowledged and usable elsewhere, institutions 9026 IV, 11. 6. 2 | cities.~ ~A 1999 World Bank/USAID survey observed that 71% 9027 II, 9. 4. 5 | in January 2003, will be usefule for developing quality assessment 9028 II, 5. 4. 1 | risk factors that can be usefully targeted as indicators of 9029 IV, 12. 10 | the creation of a European user-driven telemedicine via satellite 9030 IV, 12. 10 | implemented all over Europe upon user-request, promoting the added value 9031 II, 5. 5. 3 | Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S; WHO World 9032 III, 10. 4. 2 | migration from nylon kitchen utensils imported from China (European 9033 II, 9. 3. 1 | while cancer of the corpus uteri adds other 40 000. The effect 9034 II, 5. 1. 1 | system disorders~Exposure in utero or during development to 9035 II, 5. 15. 3 | prevalence estimate, which utilises hospital discharge records ( 9036 II, 5. 5. 3 | quality of life and patient utilities of Parkinson’s disease. ( 9037 III, 10. 4. 2 | consumption data have been utilized.~ ~Two opinions have been 9038 II, 5. 5. 3 | relatively lower rates in Uusimaa in the south. Prevalence 9039 III, 10. 3. 1 | stop the depletion of the UV-protective ozone layer by phasing out 9040 IV, 12. 10 | Universität Darmstadt~Prog T, uve GmbH für Managementberatung 9041 III, 10. 4. 5 | have no legal owner. In Uzbekistan about 18,000 tonnes of banned 9042 II, 4. 3 | enriching humanity. Geneva, WHO: v-129.~ ~ 9043 II, 7. 2. 1 | morbidity and mortality (V01-Y98)~ ~ICD-9:~- Chapter 17 on 9044 II, 5. 3. 9 | Ann Oncol 14 (suppl 5):v128-v149.~ ~ESMO (2006): Medical 9045 II, 5. 3. 9 | registry areas. Ann Oncol 14:v28-v40.~ ~Micheli A, Berrino F, 9046 II, 5. 3. 9 | Ann Oncol 14 (suppl 5):v61-v118.~ ~Stewart BW, Kleihues 9047 II, 5. 1. 4 | with the disease while on vacation.~ ~· Driving and possible 9048 II, 5. 6. 6 | and Lindgren B (1996): Vad kostar sjukdomarna? (What 9049 II, 9. 3. 1 | in some women, vaginitis, vaginimus, and dispareunia. Loss of 9050 IV, 11. 6. 4 | tax-funded NHS-style systems. The vaguest definition of benefits can 9051 IV, 11. 6. 5 | 19: 473-91.~ ~Zentner A, Valasco-Garrido M et al., (2005): "Methods 9052 II, 5. 5. 3 | Disorders in Vilnius (www.valgymosutrikimai.lt)~Luxembourg~ ~X~ ~Macedonia~ ~ 9053 IV, 11. 6. 4 | clinically relevant areas and validating them among the participating 9054 II, 5. 5. 3 | screening procedures and validations differed considerably in 9055 II, 5. 6. 6 | Cats A, Vandenbroucke JP, Valkenburg HA (1989): Epidemiology 9056 II, 5. 5. 3 | of multiple sclerosis in Valladolid, northern Spain. J Neurol 9057 III, 10. 4. 2 | veterinārais dienests~Latvia~Valstybineë maisto ir veterinarijos 9058 IV, 12. 10 | terveydenhuollon suunnittelusta ja valtionosuuksista?], which was amended in 9059 II, 9. 2. 3 | but though this project is valuably indicating the scale of 9060 IV, 11. 6. 3 | this may result from higher value-added taxes on luxury goods). 9061 IV, 12. 2 | principles include taking a value-driven approach, recognising the 9062 II, 5. 9. 4 | specific elements of PM such as vanadium (V), nickel (Ni), zinc ( 9063 II, 5. 6. 6 | van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA (1989): 9064 II, 5. 7. 7 | 20.~Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, 9065 II, 5. 5. 3 | Wilkins; 435–457.~Celius EG, Vandvik B (2001): Multiple sclerosis 9066 II, 5. 5. 3 | Smeets VMJ, van Lierop BAG, Vanhoutvin JPG, et al (2007): Epilepsy 9067 II, 5. 12. 7 | Doffoel M, Boudjema K, Vanlemmens C, Mantion G, Messner M, 9068 II, 5. 5. 3 | M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto 9069 II, 5. 8. 2 | chemicals, gases, fumes or vapours ( J6 ~· interstitial ( J9 · 9070 III, 10. 2. 1 | Greiner F, Zajkás G, Szórád I, Varga A, Domonkos A, Agoston H, 9071 II, 6. 3. 5 | will be, licensed (against varicella (chickenpox), human papilloma 9072 II, 5. 11. 3 | eczema, pompholyx eczema, varicose eczema, photosensitive eczema 9073 II, 5. 2. 7 | McQueen M, Budaj A, Pais P, Varigo J, Lisheng A (2004): Effect 9074 II, 5. 11. 3 | Riekki R, Turjanmaa K, Varjonen E, Vuorela AM, Patch test 9075 IV, 12. 10 | Solvents in Certain Paints, Varnishes and Vehicle Refinishing 9076 III, 10. 4. 2 | správa~Slovakia~Direktorat za varno hrano~Slovenia~Agencia Española 9077 II, 5. 2. 7 | Dis 18: S1-16.~Puska P, Vartiainen E, Tuomilehto J, Salomaa 9078 II, 9. 3. 1 | ischemic conditions in the vasculature (White and Holmes, 2006).~ ~ 9079 II, 5. 11. 3 | vascular diseases, systemic vasculitides – are regularly associated 9080 IV, 12. 4 | Kyprianou in 2004 and Androulla Vassiliou in 2008. Most health activities 9081 IV, 12. 10 | Physical activity~ Intermediate~ Low VAT for health clubs~ National 9082 II, 5. 5. 3 | Juckel G, Morrirson A, Vázquèz-Barquero JL, Hambrecht M, VON Reventlow 9083 II, 5. 6. 6 | Liang MH, Pillemer SR, Steen VD, Wolfe F (1998): Estimates 9084 II, 5. 6. 6 | Chaussade S, Cucinotta D, Veale DJ, Martin-Mola E (2004): 9085 II, 5. 7. 7 | Pontoriero G, Pozzoni P, Vecchio LD, Locatelli F (2007): 9086 III, 10. 4. 2 | al., 2001;~Fiolet & van Veen, 2001~ ~ ~ ~ ~Pesticides 9087 II, 5. 5. 3 | 345.~Bermejo F, Gabriel R, Vega S, Morales JM, Rocca WA, 9088 III, 10. 2. 1 | of adolescents practise a vegetarian nutrition but many do not 9089 I, 2. 9 | to substantial shifts in vegetation distribution. Changes in 9090 IV, 13. 7 | cartilage, tendons, arteries, veins, heart-valves, cornea, skin, 9091 II, 5. 5. 3 | Benito-Léon J, Martín E, Vela L et al (1998): Multiple 9092 IV, 11. 6. 5 | 213.~ ~Busse R, Orvain J, Velasco M, Perleth M, Drummond M, 9093 III, 10. 3. 4 | of Targovishte, Rousse, Velico Tarnovo, Stara Zagora, Haskovo, 9094 III, 10. 2. 1 | 1156.~ ~Pudule I, Jēce I, Velika B, Grīnberga D, Villeruša 9095 II, 5. 11. 7 | Danish Population. Acta Der Venereo 1992;72:456-60.~ ~Plesko 9096 II, 5. 15. 3 | Piedmont, Lombardy, Tuscany, Veneto) have implemented population-based 9097 I, 2. 7 | in collaboration with the Venice Biennale Foundation, was 9098 II, 5. 11. 3 | angio-edema, bee and wasp venom allergy, drug rashes such 9099 III, 10. 4. 1 | mites, moulds and bacteria. Ventilation-related humidity problems arise 9100 III, 10. 5. 1 | faulty equipment or lack of venting, these pollutants can accumulate 9101 IV, 13. 7. 2 | behind in other key areas. Venture capital investments in the 9102 III, 10. 5. 1 | booklets/05_small_water_systems_ver_june2005.pdf, accessed18 9103 IV, 12. 10 | Aktionsplan 2008/2009 zur Verbesserung der Arzneimitteltherapiesicherheit, 9104 III, 10. 3. 2 | und andere zinnorganische Verbindungen in Lebensmitteln und verbraucher 9105 III, 10. 3. 2 | Verbindungen in Lebensmitteln und verbraucher nachen Produkten.~ ~European 9106 IV, 12. 10 | Consumer Organisations (Verbraucherzentrale Bundesverband, VZBV, see www. - 9107 II, 8. 2. 1 | Tasse, M.J., Thompson, J.R., Verdugo, M-A, Wehmeyer, M.L. and 9108 II, 5. 12. 7 | Sanchez-Hernandez E, Rivero M, Vergara M, Martin -~ ~Ioannou G, 9109 II, 5. 5. 3 | schizophrene Psychosen. Eine vergleichende Langzeitstudie. Springer 9110 II, 5. 5. 3 | W, Boter H, Davidson M, Vergouwe Y, Keet IPM, Gheorghe MD, 9111 II, 5. 7. 7 | 92):S7-10.~Gansevoort RT, Verhave JC, Hillege HL, Burgerhof 9112 II, 9. 4. 7 | 11.07.07]~De Groot Lc., Verheijden Mw., De Henauw S., Schroll 9113 III, 10. 4. 2 | controls such as inspections, verifications, audits, sampling and testing 9114 III, 10. 5. 1 | point seems to be widely verified also in non-European contexts: 9115 IV, 12. 10 | Bundesministerium für ür Verkehr, Bau und Stadtentwicklung, 9116 II, 5. 9. 4 | Turin~Low~–~–~ ~–~High~–~ Verona~Low~Low~–~–~–~–~High~–~High~–~ 9117 III, 10. 2. 1 | Storm H, Tubiana M, Tursz T, Veronesi U, Wald N, Weber W, Zaridze 9118 II, 5. 6. 6 | Nationale Studie Naar Ziekten en Verrichtingen in de Huisartspraktijk. 9119 III, 10. 3. 2 | von Platingruppenelementen verschiedener Emittenten in Oberflächengewässer 9120 II, 5. 5. 3 | death in Parkinson disease. Versicherungsmedizin / herausgegeben von Verband 9121 III, 10. 2. 1 | 2005): Latvijas iedzïvotäju veselïbu ietekmëjošo paradumu pëtïjums, 9122 II, 5. 11. 3 | redness, scaling, fissuring, vesicles, and lichenification. In 9123 II, 5. 8. 7 | Scharling H, Fabricius P, Vestbo J (2006): Developing COPD: 9124 II, 5. 5. 3 | pattern was reported for Vestfold and for Hordaland County. 9125 III, 10. 4. 2 | Veterinaerinstituttet~Denmark~Veterinaar-ja Toiduamet~Estonia~Elintarviketurvallisuusvirasto 9126 III, 10. 4. 2 | Cyprus~Fødevarinstituttet Veterinaerinstituttet~Denmark~Veterinaar-ja Toiduamet~ 9127 III, 10. 4. 2 | Salute~Italy~Pārtikas un veterinārais dienests~Latvia~Valstybineë 9128 III, 10. 4. 2 | Latvia~Valstybineë maisto ir veterinarijos tarnyba~Lithuania~Sécurité 9129 III, 10. 4. 2 | Alimentelor~Romania~Štátna veterinárna a potravinová správa~Slovakia~ 9130 III, 10. 3. 2 | gesundheitlichen Verbraucherschutz und Vetrinärmedizin (BgVV) (2000): Triutylzinn ( 9131 II, 5. 11. 3 | consequences of atopic dermatitis vexes its bearers not only by 9132 IV, 11. 5. 4 | order to preserve organ viability). In addition, for organs 9133 III, 10. 2. 1 | toothpaste and mouthwash, vibrating floss and on-the-go mouth-freshening 9134 III, 10. 5. 3 | prevention of risks arising from vibration~ ~Work-related skin /eye / 9135 III, 10. 4. 2 | tuberculosis other than in point A, vibriosis and yersiniosis;~• parasitic 9136 II, 9. 3. 1 | strategies relating to CHD: A video-simulation experiment. Social Science & 9137 IV, 12. 10 | determinants and settings~ ~ www.vidm.gov.lv~ National Environmental 9138 III, 10. 2. 1 | dos Santos O, Camolas J, Vieira J, Carreira M, Medina L, 9139 II, 5. 8. 7 | Jimenez-Ruiz CA, Fernandez-Fau L, Viejo JL, Miravitlles M. (2004): 9140 III, 10. 2. 1 | e.pdf).~ ~Visscher TLS, Viet LA, Kroesbergen HT, Seidell 9141 II, 5. 5. 3 | at: http:www.medscape.com/viewarticle/457027.~Suvisaari JM, Haukka 9142 II, 5. 5. 3 | Sperry S, Thompson JK (2008): Viewership of Pro-Eating Disorder Websites: 9143 IV, 12. 10 | reflect a shift away from viewing health in terms of illness 9144 II, 5. 7. 7 | McKenna AM, Keating LE, Vigneux A, Stevens S, Williams A, 9145 III, 10. 2. 1(20)| or 1,500 MET minutes of vigorous-intensity activity accumulated over 9146 II, 9. 3. 3 | et Comportements Face au VIH/sida en Ile de France – 9147 III, 10. 2. 5 | Brubakk AM, Romundstad P, Vik T (2007): Prenatal smoking 9148 IV, 12. 10 | beslutning om, hvordan de vil arbejde med sundhedsfremme.~ ~ ~ 9149 I, 2. 10. 3 | perspective of earth as a “common village” is becoming more and more 9150 I, 2. 7 | designed around a series of village-style neighbourhoods to make it 9151 II, 5. 8. 7 | Urrutia I, Payo F, Olivieri M, Villani S, Van Sprundel M, Antó 9152 II, 5. 8. 7 | Masa JF, Sobradillo V, Villasante C, Jimenez-Ruiz CA, Fernandez-Fau 9153 II, 7. 7 | Eriksson L, Tingvall C, Villaveces A (2004): Preventing Road 9154 III, 10. 2. 1 | Velika B, Grīnberga D, Villeruša A, Dzērve V, Zīle S, Helasoja 9155 III, 10. 2. 1 | Kroke A, Bamia C, Karalis D, Vineis P, Palli D, Bueno-de-Mesquita 9156 I, 2. 3 | human rights that might be violated by it, should not be underestimated.~ ~ 9157 IV, 12. 10 | system penalties for the violation of the regulations.~o TV 9158 II, 8. 2. 1 | exposed to human rights violations and deprived of minimum 9159 II, 9. 5. 1 | work-related accidents) and violence-related mortality in men seem to 9160 II, 7.Acr | VRU~Vulnerable Road Users~VIP~Violence and Injury prevention~ 9161 IV, 12. 10 | Arbejdsmiljøcertifikat (2001): Virksomheder, der ønsker et arbejdsmiljøcertifikat 9162 IV, 13. 7. 3 | cardiovascular medicine, virology, and brain & behaviour, 9163 IV, 12. 1 | activities deemed necessary by virtue of other chapters of this 9164 III, 10. 4. 2 | the serotypes and other virulence factors related to human 9165 II, 6. 3. 7 | VHF in general, some on virus-specific infections, while others 9166 IV, 11. 1. 5 | approaches such as peer review/visitation, clinical audit, quality 9167 IV, 12. 8 | each country as well as visitor programmes using specific 9168 III, 10. 2. 1 | impairment of attention and visuospatial skills.~ ~It has been estimated 9169 II, 5. 12. 7 | benefits and risks. Int J Vitam Nutr Res 71:210-213.~ ~Leon 9170 III, 10. 3. 1 | Milieumaatschappij, MIRA, MIRA/2003/02, Vito. Downloadable from: htt /ME 9171 -, 1 | management of the project.~ ~ Vittorio Silano Luciano Vittozzi~ 9172 -, 1 | Vittorio Silano Luciano Vittozzi~Project Coordinator Project 9173 III, 10. 2. 5 | Dragonas T, Paradisiotou A, Vizakou S, Roberts R, Cox A, Day 9174 III, 10. 2. 1 | Kéki Z (2005): Táplálkozási vizsgálat Magyarországon, 2003-2004 [ 9175 II, 5. 7. 7 | donoghue DJ, de LS, Van VJ, Klebe B, Middleton R, et 9176 III, 10. 3. 1 | uitgevoerd in opdracht van de Vlaamse Milieumaatschappij, MIRA, 9177 II, 5. 5. 3 | Ooteghem P, De Hooghe MB, Vlietnick R, Carton H (1994): Prevalence 9178 II, 5. 5. 3 | Med 338:1715-1722.~Smeets VMJ, van Lierop BAG, Vanhoutvin 9179 III, 10. 3. 2 | Programme~US~United States~VOC~Volatile organic chemicals~ 9180 III, 10. 4. 1 | 5 ), NH3 , NOx, SO2 and VOCs and their reaction products ( 9181 III, 10. 4. 2 | Livsmedelsverket~Sweden~Voedsel en Waren Autoriteit~The 9182 II, 5. 5. 3 | Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky 9183 II, 5. 6. 6 | Ensrud KE, Cauley J, Black D, Vogt TM (1995): Risk factors 9184 II, 5. 8. 7 | Huchon G, Huas D, Godard P, Voinet C, Chanal I, Jourdanne C, 9185 II, 5. 3. 2 | oxfordjournals.org/content/vol18/suppl_3/index.dtl.~ ~ ~ ~ 9186 III, 10. 2. 1 | Individual dietary record~7~Volatier J.L. Enquête INCA Individuelle 9187 III, 10. 4. 5 | as: solubility, mobility, volatility, sorption capacity, persistence 9188 III, 10. 1. 1 | cognitive factors such as volitional control towards exercise, 9189 II, 7. 4. 4 | ball games such as soccer, volleyball, handball and basketball ( 9190 II, 5. 5. 3 | Higginson I, Pitschnau-Michel D, Voltz D (2006) Position Paper 9191 II, 5. 11. 3 | S Lisby, O Baadsgaard, A Vølund, T Menné, Decrease in nickel 9192 II, 9. 3. 3 | N, Lagarde M, Wu Zhou X, Vongmany N, Gremy I (2005) Les Connaissances, 9193 I, 2. 10. 4(11)| effect van elektronisch voorschrijven en electroninische toedienregistratie 9194 IV, 12. 10 | zivilrechtlichen Schutz vor Gewalttaten und Nachstellungen, 9195 III, 10. 2. 4 | Lunshof JE, Chadwik R, Vorhaus DB, Church GM (2008): From 9196 IV, 12. 10 | Proportion of young first-time voters (general elections)~ ~Domain 9197 II, 7.Acr | Standardised Death Rate~VRU~Vulnerable Road Users~VIP~ 9198 II, 7. 4. 3 | 300 vulnerable road users (VRUs: pedestrians, cyclists and 9199 III, 10. 4. 2 | the databases to identify vulnerabilities due to eating habits. High 9200 III, 10. 4. 2 | wound infection~ ~High (V. vulnificus),~ ~ ~ ~Medium (other)~Yersinia 9201 II, 9. 3. 1 | population-based study of vulvar cancer. J Natl Cancer Inst, 9202 II, 5. 11. 3 | Turjanmaa K, Varjonen E, Vuorela AM, Patch test reactions 9203 II, 9. 5. 6 | Lindholm G (1995): ÎSkolgrden, -vuxnas bilder -barns miljñÌ~ ~Michels 9204 III, 10. 4. 2 | cereals.~ ~Monitoring by VWA~and food industry~ ~Pieters 9205 III, 10. 2. 1 | Antropometrické ukazovatele a ich využitie na sledovanie trendov telesného 9206 III, 10. 2. 1 | sledovanie trendov telesného vývinu detí a mládeže [Anthropometric 9207 III, 10. 2. 1 | Authority (2004): Telesný vývoj detí a mládeže v Slovenskej 9208 IV, 12. 10 | Verbraucherzentrale Bundesverband, VZBV, see www. - umbrella organization 9209 III, 10. 1. 3 | Eliakim A, Brasel JA, Lee W-NP, Burke G, Cooper DM (1998): 9210 II, 9. 3. 1 | Internal Medicine 148(9): 680-W137.~ ~Shah, J., (2002) Erectile 9211 IV, 11. 6. 5 | Jan-Jun(Suppl Web Exclusives): W5-97-W5-107.~ ~Taggiasco , Sarrut 9212 III, 10. 3. 1 | Estimation. Umweltbundesambt. WaBoLu Hefte 01/06. [On-line publication 9213 II, 5. 4. 8 | Gfrerer, R, Trajanoski, Z, Wach, P, and Pieber, T. (2001) 9214 III, 10. 2. 4 | Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng 9215 III, 10. 4. 2 | Monitoring; autumn~2002 Wadden Sea~fishing grounds~temporarily 9216 II, 9. 4. 7 | Jaleel H, Allan P S, Wade A A (1999): Sexually transmitted 9217 II, 9. 3. 3 | STD&AIDS 15:56-60~Bajos N, Wadsworth J, Ducot B, Johnson AM, 9218 II, 5. 5. 3 | Sudden death in epilepsy: a wake-up call for management. Lancet 9219 II, 5. 10. 7 | Kowalski M, Papadopoulos NG, Wal JM, Clare Mills EN, Vieths 9220 II, 9. 5. 6 | pdf~ ~Women’s Aid (citing Walby & Allen) (2004):~ht 07 Available 9221 III, 10. 2. 1 | European Commission (2000b): WalCyng: How to enhance WALking 9222 III, 10. 2. 1 | M, Tursz T, Veronesi U, Wald N, Weber W, Zaridze DG, 9223 III, 10. 5. 1 | by children (1257-RP).~ ~Walinder R, Gunnarsson K, Runeson 9224 III, 10. 5. 1 | stress reactions in pupils (Wålinder et al, 2007).~ ~Therefore, 9225 III, 10. 5. 1 | areas: the importance of walkable green spaces. In: Journal 9226 III, 10. 6. 1 | 15 year old girls in the Walloon region report easy communication 9227 III, 10. 2. 1 | Navarro C, Martinez GC, Wallstrom P, Zhang JX, Welch AA, Spencer 9228 II, 5. 10. 2 | crayfish), tree nuts (almonds, walnuts, hazelnuts, Brazil nuts 9229 II, 5. 6. 6 | Sisitsky T, Auerbach R, Wanke LA, Buatti MC (2000): Direct 9230 II, 5. 11. 7 | Weismann K, Krakauer R, Wanscher B (1980): Prevalence of 9231 IV, 11. 1. 3 | resources are used to attain wanted outcomes – and, ultimately, 9232 III, 10. 2. 4 | Lehmann DJ, Cortina-Borja M, Warden DR, Smith D, Sleegens K, 9233 III, 10. 2. 1 | Moody A, Stamatakis E, Wardle H (2005): Obesity among 9234 III, 10. 4. 2 | Livsmedelsverket~Sweden~Voedsel en Waren Autoriteit~The Netherlands~ 9235 IV, 12. 10 | product testing (Stiftung Warentest, see www. – independent 9236 II, 6. 3. 7 | recorded as a biological warfare agent since 1941.~ ~Over 9237 II, 6. 3. 7 | and it occurs worldwide in warm-blooded mammals. The transmission 9238 I, 2. 9 | for land alone. Europe has warmed more than the global average ( 9239 III, 10. 3. 4 | have accelerated. The 10 warmest years on record occurred 9240 I, 2. 9 | than the global average.~ ~Warming of surface water can have 9241 II, 5. 5. 3 | aggressive treatment is warranted in all patients with MS 9242 II, 9. 5. 1 | prepare men to fight in wars or to work in hazardous 9243 IV, 12. 10 | public to report failures~to wash hands~ ~Publication of annual 9244 II, 6. 3. 6 | cats or from inadequately washed contaminated fruits or vegetables, 9245 II, 5. 11. 3 | and angio-edema, bee and wasp venom allergy, drug rashes 9246 III, 10. 3. 2 | Zischka, C Pettersson, U Wass, M Luna, JC Saenz, J Santamaria ( 9247 II, 9. 3. 1 | 14: 256-262~ ~Braun, M., Wassner, G Klotz, T Reifenrath, 9248 III, 10. 4. 5 | and effect, and compare waste-related exposures with those due 9249 II, 9. 5. 4 | Framework Programme (FP5) Gender Watch System, to examine earlier 9250 IV, 13. 8 | In addition, NGOs act as watchdogs. However, NG0s benefit from 9251 IV, 12. 10 | use like snuff or shisha/waterpipe are also addressed.~Increases 9252 III, 10. 4. 1 | M.,Hurley, F., Pye S., Watkiss P. and Hunt A. (2007) improving 9253 II, 5. 4. 6 | already present.~According to Waugh et al (2007), the scope 9254 III, 10. 3. 1 | filters most of the shorter wavelength UV-B and the UV-C, but the 9255 II, 7. 7 | Schopper D, Lormand JD, Waxweiler R (Eds.) (2006): Developing 9256 III, 10. 4. 5 | Switzerland and Liechtenstein)~WCE~Western and Central Europe~ 9257 III, 10. 2. 1 | Education.~ ~Brettschneider WD, Naul R (2004): Study on 9258 II, 5. 5. 1 | disease as Work Days Lost (WDL).~ ~About one in three or 9259 II, 5. 4. 6 | Screening may be an important weapon in the secondary prevention 9260 II, 6. 3. 2 | one of its most important weapons against infectious diseases.~ ~ 9261 IV, 12. 10 | obesity, BzGA provides a web-site focusing on eating disorders (www e) 9262 IV, 12. 10 | non-smoking activities such as web-sites and internet-platforms for 9263 III, 10. 4. 2 | including its corporate website, webcasting, participation in events 9264 II, 5. 6. 6 | Badley EM, Rasooly I, Webster GK (1994) Relative importance 9265 III, 10. 4. 2 | recommendations on the "Weeds to revise the Community 9266 II, 5. 4. 8 | Armesto SG, Lapetra ML, Wei L, Kelley E and the Members 9267 III, 10. 2. 1 | German): ht ~ ~Elmadfa I, Weichselbaum E (eds) (2005): European 9268 III, 10. 4. 2 | quantitative one) to compare/weigh the potential risk against 9269 IV, 11. 1. 5 | services. Each indicator is weighed, contributing to an overall 9270 II, 9. 2. 3 | underweight and to engage in weight-gaining and muscle-enhancing activities ( 9271 IV, 11. 6. 4 | established based on crude weightings of age and sex. More sophisticated 9272 III, 10. 2. 1 | Fernandez Feito A, Mattisson I, Weinehall L, Riboli E, Slimani N ( 9273 II, 5. 10. 7 | Abramson M, Raven JM, Bailey M, Weiner JM, Walters EH et al (1998): 9274 II, 5. 5. 3 | ahead of print].~Gaebel W, Weinmann S, Sartorius N, Rutz W, 9275 II, 5. 5. 3 | Lucchinetti C, Rodriguez M, Weinshenker BG (2000): Multiple sclerosis. 9276 III, 10. 2. 1 | Sekula W., Nelson M., Weisell R.C.: The Household Food 9277 III, 10. 5. 1 | Knowledge Network on Water WEKNOW, 2005 (http://www. weknow-waternetwork. 9278 III, 10. 5. 1 | WEKNOW, 2005 (http://www. weknow-waternetwork.com/uploads/booklets/05_ 9279 II, 5. 7. 7 | EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al (2003): 9280 II, 9. 2. 3 | world where there has been a welcomed reduction in infectious 9281 IV, 13. 8 | European Commission, 2001) In welcoming the expanding role and diversity 9282 III, 10. 3. 4 | as populations are less well-adapted to cold . However, cold 9283 III, 10. 4. 2 | Human Health. During this well-attended international meeting, an 9284 II, 5. 5. 3 | but due to a paucity of well-controlled randomized studies, a final 9285 II, 6. 4. 1 | are greatly facilitated by well-functioning surveillance systems. Surveillance 9286 IV, 11. 1. 1 | their own context based on well-informed comparative research. The 9287 II, 8. 2. 2 | integrated into well managed, well-monitored national health systems.~ ~ 9288 II, 5. 5. 3 | adolescents to have a normal and well-ordered life and development.~The 9289 II, 5. 2. 4 | Project is an example of well-recognised approach to community-based 9290 IV, 13. 6. 2 | physician is generically well-understood, but there is no common 9291 II, 9. 3. 3 | Herlitz et al, 2005), Britain (Wellingset al, 2001), UK (Johnson et 9292 III, 10. 4. 3 | water and groundwater as welll as of water quantity and 9293 II, 5. 2. 4 | a reduced CVD incidence (Wellman J, 2004).~Due to differences 9294 III, 10. 2. 1 | McNamara H, Joseph KS, Wen SW (2002): Why are babies 9295 II, 8. 2. 1 | 32% (Rantakallio and von Wendt, 1986). Prevalence of severe 9296 II, 5. 2. 6 | 46: 1855-1862.~Stamler J, Wentworth D, Neaton JD (1986). Is 9297 II, 5. 5. 3 | Mackeprang T, Hansson L, Werdelin G, Karlsson H, Bjarnason 9298 II, 5. 8. 7 | Wagena E, Akkermans RP, Wesseling GJ (2002): Detecting patients 9299 I, 2. 10. 4(11)| toedienfouten”, Elsbeth Wesselink, Gerle Ziekenhuizen, 10 9300 III, 10. 5. 1 | comparative EU-funded study in west-Europe found low ventilation rate 9301 II, 5. 5. 3 | 343-350.~Callenbach PM, Westendorp RG, Geertz AT, et al (2001): 9302 II, 5. 5. 3 | 3:35-36.~Shackleton DP, Westerndorp RGJ, Kastelejin-Nolst Trenite 9303 II, 6. 3. 4 | Industrialised countries with Westernised economies where TB rates 9304 III, 10. 3. 2 | Lancet 368, 2167-2178.~ ~Westfälisches Institut für Wasserforschung ( 9305 I, 2. 10. 4(12)| Celsea an Westmenister Healthcare NHS Trust, K. 9306 I, 2. 10. 4 | to 0.84%)11. Chelsea and Westminster Healthcare NHS Trust, UK, 9307 II, 9. 3. 3 | Prevention.~Shepherd J, Weston R, Peersman G, Napuli IZ, 9308 III, 10. 6. 1 | Kessler R, McLeod J, Wethington E. The cost of caring: a 9309 III, 10. 4. 2 | in soil organisms), ( 2 WGs are working in parallel).~ ~ 9310 II, 5. 5.Int(13)| int/gb/archive/pdf_files/WHA55/ea5518.pdf]~ 9311 III, 10. 2. 1 | Health Assembly resolution WHA57.17 on a global strategy 9312 II, 9. 5. 4 | harmful use of alcohol (WHA58.26[53]) of 2005, which recognizes 9313 III, 10. 3. 2 | predators, such as seals, whales, dolphins and polar bears 9314 II, 5. 5. 3 | to patients restricted to wheelchairs, confined to bed and totally 9315 II, 5. 7. 7 | 44.~Baigent C, Burbury K, Wheeler D (2000): Premature cardiovascular 9316 | whence 9317 | wherein 9318 II, 7. 4. 3 | road users were injured whereof 1.3 million were bicyclists. 9319 II, 5. 10. 5 | from soybean sources.~ ~(d) whey used for making distillates 9320 II, 5. 14. 3 | 1.1 DMFT, France at 1.1, whilethe corresponding figure for 9321 III, 10. 2. 4 | S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, 9322 IV, 12. 10 | act as input to a national white-paper expected in 2009/10.~ ~The 9323 II, 5. 6. 6 | psychiatric illness: the Whitehall II Study. Soc Sci Med 40: 9324 III, 10. 2. 1 | toothbrushes, toothpaste and tooth whiteners. Toothpaste constitutes 9325 III, 10. 3. 1 | Tirmarche M, Tomáek L, Whitley E, Wichmann HE, Doll R, ( 9326 II, 5. 2. 6 | 1159-1166.~Lewington S, Whitlock G, Clarke R, Sherliker P, 9327 III, 10. 3. 2 | for long-range transport, whlile acrylamide is given as an 9328 III, 10. 1. 3 | Melzer K, Kayser B, Saris WHM, Pichard C (2005): Effects 9329 II, 5. 5. 3 | misallocation of resources~The WHO-Atlas on Mental Health delivers 9330 III, 10. 4. 3 | variations. Further, data for the WHO-European Region show that coverage 9331 II, 5. 5. 1 | some discrepancies between WHO-HFO and EUROSTAT due to different 9332 II, 5. 5. 3 | gap as demonstrated in the WHO-initiated World Mental Health Surveys ( 9333 IV, 12. 10 | for general population (WHO-initiativeQuit & Win”, see www.rauchfrei2008. 9334 IV, 11. 3. 1 | through agencies such as the WHO-sponsored World Federation for Medical 9335 III, 10. 4. 2 | weekly intake (TWI) of 14 pg WHO-TEQ/kg body weight for dioxins 9336 III, 10. 2. 1 | obesity. Macroeconomic and whole-of-government interventions (e.g. taxation 9337 III, 10. 2. 1 | obesity in schools where the whole-school approach is adopted. Studies 9338 III, 10. 2. 1 | fruit and vegetables and wholemeal products.~ ~Table 10.2.1. 9339 IV, 11. 6. 2 | CEE countries is almost wholly driven by an increase in 9340 II, 9. 5. 6 | Geneva. Available at: http://whqlibdoc.who.int/hq/2000/who_msd_ 9341 IV, 13. 9 | http://www.who.int/entity/whr/2003/en/whr03_en.pdf]~ ~ 9342 IV, 13. 9 | who.int/entity/whr/2003/en/whr03_en.pdf]~ ~WHO (2005): The 9343 II, 5. 5. 3 | Pathol 6:259-274.~Mc Donald WI, Compston A, Edan G, et 9344 II, 5. 5. 3 | Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, 9345 II, 5. 9. 7 | EA, Custis N, Ronmark E, Wickens K, Sporik R, Woodfolk JA, 9346 II, 5. 3. 8 | European Union can promote a wide-range debate to find ways of reducing 9347 III, 10. 4. 2 | set-up to facilitate and widen the dissemination of animal 9348 II, 9. 2. 3 | than boys. The gender gap widens with age (Fig. 2). On average, 9349 II, 5. 5. 3 | Isacson D, Bingefors K, Widerlöv B (2007): Mortality among 9350 II, 5. 5. 3 | Gilbert CC, Bergman P, Widhalm K, Manios Y, Breidenasse 9351 II, 9. 4. 3 | divorced, separated or widow/widowers. Their single status often 9352 II, 5. 7. 7 | 21(8):2178-83.~Tonelli M, Wiebe N, Culleton B, House A, 9353 II, 5. 5. 3 | drug-induced changes in metabolism. Wien Klin Wochenschr 118 (7-8): 9354 II, 5. 5. 3 | 338:278-285.~Trisolini M, Wiener J, Miller D (2002): Principles 9355 III, 10. 2. 4 | Cox N J, Wichmann H E, Wienker T F, Schulze J, Schwarz 9356 III, 10. 2. 1 | of the population 2005]. Wiesbaden, Federal Statistical Office ( 9357 II, 9. 1. 2 | S, Physick N, Tenconi R, Wiesel A, Calzolari E, Stone D ( 9358 II, 5. 10. 7 | E, Mothes T, Troncone R, Wieser H (2001): Analysis and clinical 9359 III, 10. 2. 1 | 61:743-751.~ ~Paccaud F, Wietlisbach V, Rickenbach M (2001): 9360 II, 5. 5. 3 | study made on the Isle of Wight found children with epilepsy 9361 II, 5. 6. 6 | 42(4):516-21~Kallman DA, Wigley FM, Scott WW, Jr., Hochberg 9362 III, 10. 4. 2 | but severe consequences~ ~Wildilife~Source: EFSA~ ~ ~Table 10. 9363 II, 9. 3. 1 | accessed 07.07)~ ~Brownhill S, Wilhelm K, Barclay L & Schmied V ( 9364 II, 5. 3. 9 | 94:606-616.~ ~Jonsson B, Wilking N (2007): Summary. Ann Onc 9365 II, 5. 5. 3 | Reid WG, OSullivan DJ, Williamson PM (1999): The sydney multicentre 9366 II, 9. 5. 6 | caregiving. (Edited by: Willson K). Aurora, Ontario: Garamond 9367 IV, 12. 10 | WHO-initiative “Quit & Win”, see www.rauchfrei2008. 9368 III, 10. 2. 1 | synergies involved create a win-win situation for all actors. 9369 III, 10. 5. 1 | building, mostly through open windows but – in the case of noise9370 III, 10. 4. 5 | spray is inhaled during windy days.~ ~“Swimmers Itch” 9371 II, 9. 3. 3 | Bernhardt JM, Burgess-Whitman N, Wingood GM (2005): Adolescents’ 9372 II, 5. 7. 3 | marred with difficulties (Winkelmayer et al, 2005). No data has 9373 III, 10. 3. 4 | Commission’s Communication "Winning the Battle against Global 9374 III, 10. 4. 2 | fire~ retardants 2003~ ~De Winter-Sorkina et al.,~2003~ ~ ~Community 9375 III, 10. 2. 1 | and carbohydrate sources (Wirfalt et al, 2002) have been described 9376 II, 5. 5. 3 | Ergebnisse von Metaanalysen zur Wirksamkeit. Psychiat Prax 34(1):S28-S32.~ 9377 II, 9. 5. 6 | Schneekloth U, Müller U (2000): Wirkungen der Plfegeversicherung. 9378 IV, 11. 5. 4 | and to communicate their wishes to their relatives. Only 9379 III, 10. 2. 1 | powerful deterrent for parents wishing to allow their children 9380 II, 9. 2. 7 | accessed 12.01.07)~ ~Ståhl T, Wismar M, Ollila E, Lahtinen E, 9381 III, 10. 4. 2 | third country, to refuse, withdraw or modify authorisations 9382 III, 10. 2. 1 | quit smoking should not be withheld a less hazardous form of 9383 III, 10. 2. 1 | reducing the variance of within-subject variations due to random 9384 III, 10. 2. 1 | M, Stokes E, Sumnall H, Witty K, Bellis M (2007): A review 9385 III, 10. 2. 1 | Neukirch F, Vermeire P, Wjst M and Burney P (2006): Changes 9386 III, 10. 2. 1 | Monteiro CA, Moura EC, Conde WL, Popkin BM (2004): Socioeconomic 9387 II, 5. 5. 3 | in metabolism. Wien Klin Wochenschr 118 (7-8):196-206.~European 9388 III, 10. 2. 4 | Zika E, Papatryfon I, Wolf O, Gómez-Barbero M, Stein 9389 II, 5. 11. 3 | IM Freedberg, AZ Eisen, K Wolff, KF Austen, LA Goldsmith, 9390 II, 9. 2. 6 | the child begins in the womb, hence parental nutrition, 9391 III, 10. 2. 1 | literature. Journal of Midwifery Womens Health 48:338345.~ ~European 9392 II, 5. 9. 7 | E, Wickens K, Sporik R, Woodfolk JA, Platts-Mills TA (2005): 9393 II, 5. 5. 3 | 52.~Carney CP, Jones L, Woolson RF (2006): Medical comorbidity 9394 III, 10. 2. 1 | is measured while data on work-, transport- or domestic-related 9395 IV, 13. 4 | Member States facing such work-force shortages, adequate recruitment, 9396 I, 2. 4 | they live in jobless or low work-intensity households or because their 9397 III, 10. 1. 1 | stigmatized when participating in work-out classes in which the great 9398 Key, Ap5. 0. 0 | workers~workforce~working~work-place~wound~wrist~ 9399 III, 10. 5. 3 | 391 (Framework), 89/654 (Work-places), 89/655 (Work Equipment), 9400 III, 10. 5. 3 | career and promoting the workability of ageing workers.~ ~New 9401 II, 5. 9. 3 | health resources and loss of workdays. For a better evaluation 9402 I, 2. 10. 3 | allow for the development of worker-centric, flexible, scalable and 9403 II, 5. 4. 2 | their families, friends and workmates:~ ~-> Management of their 9404 III, 10. 2. 1 | and obesity in school and worksite settings: a report on recommendations 9405 IV, 12. 10 | nutrition and ergonomics at the workstation~www. de Prevention at the 9406 III, 10. 5. 3 | layout of workplaces and workstations~- information, instruction 9407 II, 9. 3. 1 | A complete diagnostic workup is mandatory before taking 9408 II, 5. 5. 2 | et al analysed the 14 WHO worlds regions but for our calculations, 9409 II, 5. 5. 3 | Miller, K.K, Almazan, C, Worley, M,. Soyka, L.A, Herzog, 9410 III, 10. 1. 1 | of anxiety, stress, and worries (Bondy, 1996; Pohorecky, 9411 II, 9. 2. 2 | is their state of health? Worryingly, neither of these questions 9412 II, 5. 6. 6 | Care 6:669-678~Linos A, Worthington JW, O'Fallon WM, Kurland 9413 III, 10. 2. 1 | group, they are essentially worthless. Communication should be 9414 II, 9. 2. 2 | is usually not considered worthwhile or justified, and this appears 9415 II, 5. 11. 3 | bullous diseases, chronic wounds such as venous and decubitus 9416 II, 5. 5. 2 | Europe (2007): EuroCoDe, WP4 survey on social support 9417 II, 5. 9. FB | Associations~- The SCALE strategy~- WP5: Clustering of European 9418 II, 5. 5. 3 | Further validation of the WPSI vocational scale: comparisons 9419 III, 10. 2. 1 | and Statistics.~ ~James WPT, Jackson-Leach R, Mhurchu 9420 II, 5. 8. 7 | Schols AM, Postma DS, Pieters WR, Roldaan AC, Wouters EF ( 9421 I, 2. 10. 4 | of patient identity via a wristband, enabling the introduction 9422 I, 2. 10. 4 | identification codes on wristbands.” 22~ ~ 9423 II, 9. 4. 3 | many do not use condoms. Wrongly considered to be at low 9424 II, 5. 6. 6 | Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud 9425 III, 10. 4. 3 | catchment to consumer. WHO/SDE/WSH/05.06. Available at: htt ml~ 9426 II, 9. 3. 3 | neighbouring countries). Helsinki:WSOY.~Haavio-Mannila E, Kontula 9427 III, 10. 4. 3 | supports the development of WSPs and is one of the drivers 9428 III, 10. 2. 1 | antropometryczne przeprowadzone wśród 4153 osób [Nutritional status 9429 III, 10. 4. 2 | al, 2004; Greenpeace and WWF, 2005). This gives special 9430 II, 9. 2. 7 | com/csi/eurosafe2006.nsf/wwwVwContent/l3childsafetyactionplanning. 9431 II, 9. 3. 3 | P, da Silva MO, Astin M, Wyness L, Bloemenkamp KWM, Jahn 9432 II, 5. 2. 3 | hospital discharge rates (x100.000) from all CVD, IHD,AMI, 9433 II, 7. 7 | and intentional self-harm (X60-X84). EU27, 3 year average of 9434 II, 7. 7 | inhabitants), Homicide, assault (X85-Y09). EU27, 3 year average of 9435 III, 10. 4. 2 | how a number of organica xenobiotic chemicals have been detected 9436 IV, 12. 10 | Protection with the code nameXenokratis”, which among others determines 9437 IV, 12. 10 | 2. combating racism and xenophobia in relation to the labor 9438 IV, 12. 10 | Sozialgesetzbuch (Social Security Code XII) Social Welfare: §67, §68 [ 9439 IV, 11. 6. 5 | of Economics Literature XL: 881-906.~ ~De Graeve D, 9440 II, 5. 14. 8 | www.cecdo.org/pages/EUEEA.xls (article online, accessed 9441 III, 10. 2. 1 | Body mass index in 7-9-y-old French children: frequency 9442 III, 10. 2. 1 | Chadjigeorgiou C, Kourides YA, Savva ME, Panagi A, Chrictodoulou 9443 II, 5. 7. 1 | Health Organization, 2005; Yach et al, 2004). However, it 9444 II, 5. 2. 7 | Daviglus ML, Liu K, Pirzada A, Yan LL, Garside DB, Greenland 9445 III, 10. 1. 3 | PM, Sallis JF, King AC, Yancey AK, Franklin BA, Buchner 9446 I, 2. 7 | China at the mouth of the Yangtze River. The 86 square km 9447 II, 5. 5. 3 | 40.~Lysaker PH, Tsai J, Yanos P, Roe D (2007): Associations 9448 II, 5. 6. 6 | Nielsen H, Silman A, Smolen J, Yazici H (2007): EULAR Recommendations 9449 | Ye 9450 III, 10. 2. 1 | Katz DL, OConnell M, Yeh MC, Nawaz H, Njike V, Anderson 9451 III, 10. 4. 2 | Verotoxigenic Escherichia coli and Yersinosis ~Considerable~Unclear~Unclear~ 9452 III, 10. 4. 2 | Czech Republic~Υπουργείου Υγείας της Κυπριακής Δημοκρατίας~ 9453 IV, 11. 1. 3 | by the WHO in 2000, which yielded a ranking of health systems 9454 III, 10. 5. 1 | 539.~Norback D, Tao J, Mi YL, Ferm M, (2000) Current 9455 III, 10. 5. 1 | Palonen, J, Tuomisto, JT, Yli-Tuomi, T, Seppänen, O, Jantunen, 9456 II, 5. 5. 3 | Of Life With Disability~YLL~Years Of Life Lost~ ~ ~ ~ 9457 II, 5. 5. 3 | mortality (years of life lost, YLLs) and of lifetime adjusted 9458 II, 5. 11. 3 | 4%,1-year prevalence=10%~Yngveson M, et al~ ~Danish school 9459 II, 7. 7 | N, Sethi D, Racioppi F, Yordi Aguirre I, Baumgarten I ( 9460 III, 10. 4. 2 | Uno, A, Saijo, Y, Sata, F, Yoshimura, Y, Kishi, R, Nakazawa, 9461 II, 9. 3. 3 | Family Health International (YouthNet Program).~Klavs I, Rodrigues 9462 II, 5. 2. 7 | study [htt rg/doi:10.1016/j.ypmed.2008.01.023] (accessed on 9463 III, 10. 4. 2 | inspekce~Czech Republic~Υπουργείου Υγείας της Κυπριακής Δημοκρατίας~ 9464 II, 5. 9. 4 | clinical asthma among 13- to 14-yr-old adolescents seem to be significantly 9465 II, 5. 9. FB | allergic diseases at 1847 ys of age (Bener et al, 2007). 9466 III, 10. 2. 1 | Bueno-de-Mesquita HB, van der Schouw YT, Engeset D, Skeie G, Tormo 9467 III, 10. 2. 5 | former Federal Republic of Yugoslavia, and it provides the only 9468 II, 5. 5. 3 | Psychiatry 75;711-716.~Tola MA, Yugueros MI, Fernández-Buey N, Fernández-Herranz 9469 II, 5. 5. 3 | 1791.~Rutter M, Graham P, Yule W (1970): A neuropsychiatric 9470 -, 1 | Committee (Peter Achterberg, Yves Charpak, Pietro Folino Gallo, 9471 III, 10. 4. 2 | správa~Slovakia~Direktorat za varno hrano~Slovenia~Agencia 9472 III, 10. 3. 4 | Rousse, Velico Tarnovo, Stara Zagora, Haskovo, Pazardzik, Shoumen 9473 II, 4. 3 | Policies. B. Marin and A. Zaidi. Aldershot - Brookfield 9474 III, 10. 2. 1 | Rodler I, Bíró L, Greiner F, Zajkás G, Szórád I, Varga A, Domonkos 9475 II, 5. 12. 7 | Corrao G, Ferrari P, Zambon A, Torchio P, Arico S, Decarli 9476 II, 5. 7. 7 | Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo 9477 II, 5. 3. 2 | Registry roles and functions (Zanetti and Primic-Zakelj, 2007)~ ~ 9478 III, 10. 5. 1 | Garber, 2007; Rogers and Zaragoza, 2003). In addition, green 9479 III, 10. 5. 1 | 3): 328-339~Rogers MAM, Zaragoza-Lao E: Happiness and children9480 III, 10. 2. 1 | Veronesi U, Wald N, Weber W, Zaridze DG, Zatonski W, zur Hausen 9481 II, 5. 5. 3 | Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji 9482 II, 5. 7. 7 | FT, Nieuwenhuizen MG, de ZD, et al (2004): Trends in 9483 III, 10. 4. 2 | Monitoring~ ~WHO, 1996~Zearalenone~ ~Maize, wheat~Oestrogenic 9484 III, 10. 5. 2 | Presentation held by Jouke van der Zee et al. (Netherlands Institute 9485 III, 10. 3. 1 | B (2006) Prüss-Üstün A, Zeeb H, Mathers C, RepacholiM ( 9486 III, 10. 4. 2 | Forestry~Bulgaria~Státní zemìdìlské a potravináøské inspekce~ 9487 III, 10. 2. 1 | 242-247.~ ~Luo J, Ye W, Zendehdel K, Adami J, Adami H-O, Bofetta 9488 II, 5. 7. 7 | 1296-305.~Gorodetskaya I, Zenios S, McCulloch CE, Bostrom 9489 II, 5. 8. 7 | Jakobsson P, Molstad S, Zetterstrom O. (2004): Early detection 9490 II, 5. 8. 7 | Ko FW, Liu SM, Zheng JP, Zhong NS, Ip MS, Vermeire PA. 9491 II, 9. 3. 3 | Beltzer N, Lagarde M, Wu Zhou X, Vongmany N, Gremy I ( 9492 III, 10. 2. 1 | Steinberg MB, Williams JM, Ziedonis DM (2006): Developments 9493 II, 5. 5. 3 | Moutard-Martin F, Dujardin M, Ziegler M (1999): Cost of illness 9494 II, 5. 6. 6 | Een Nationale Studie Naar Ziekten en Verrichtingen in de Huisartspraktijk. 9495 III, 10. 2. 1 | Villeruša A, Dzērve V, Zīle S, Helasoja V, Paalanen 9496 II, 6. 3. 7 | traveller returning from Zimbabwe. No cases were reported 9497 III, 10. 2. 1 | 4: 537-545.~ ~Kraemer K, Zimmermann MB (ed.). Nutritional anaemia. 9498 III, 10. 2. 4 | A, Schröder P, Brand H, Zimmern R (2006): Getting Ready 9499 II, 5. 7. 7 | Dunstan DW, Welborn TA, Zimmet PZ, et al (2003): Prevalence 9500 II, 5. 15. 6 | Israeli A, Chertkoff R, Zimran A (2006): National health 9501 III, 10. 3. 2 | Triutylzinn (TBT) und andere zinnorganische Verbindungen in Lebensmitteln 9502 III, 10. 3. 2 | B Bocca, P Schramel, M Zischka, C Pettersson, U Wass, M 9503 IV, 12. 10 | Protection Act (Gesetz zum zivilrechtlichen Schutz vor Gewalttaten und 9504 II, 5. 5. 3 | 13(3):406-413.~Clarke CE, Zobkiw RM, Gullaksen E (1995): 9505 II, 5. 6. 6 | Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological